Latest news
Loading news…
Telavant
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Nyack, New York, United States Founded 2022 11-50 employees For Profit
Telavant is developing novel medicines to assist patients suffering from inflammatory and fibrotic disorders.
Telavant on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Telavant was acquired by Roche in 2023 for $7.1B.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
2
About Telavant
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 16
- HQ
- Nyack, New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Oct 23, 2023
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- 0.2
- Trend (30d)
- 2.4
- Trend (90d)
- 4
2
professional contacts at Telavant
Contact execs at Telavant →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Telavant
Loading news…
FAQs about Telavant
People who checked this page also checked these
Browse the full Acquirezy directory.